Related Experiment Video
Updated: Sep 19, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
381
Quantification of Postdiagnosis Cancer Patient Navigation
Sarojini Posani1, Ursula J Burnette2, Shearwood McClelland1,3
1Departments of Radiation Oncology.
American Journal of Clinical Oncology
|June 17, 2025
Summary
This study highlights the need for standardized metrics in cancer patient navigation. Current data shows wide variability in navigator-patient contacts and time spent, impacting care outcomes.
Area of Science:
- Oncology
- Healthcare Management
- Health Services Research
Background:
- Patient navigation is crucial for optimal cancer care outcomes.
- Existing literature confirms patient navigation benefits, but objective data on key metrics is limited.
- Understanding navigation metrics like patient contacts and time spent is essential for improving cancer care.
Purpose of the Study:
- To systematically review published literature on cancer patient navigation metrics.
- To analyze data on navigator-patient contacts, time spent, barriers addressed, and outcomes.
- To compare findings with the Navigator-Assisted Hypofractionation (NAVAH) trial.
Main Methods:
- A systematic PubMed search was conducted in April 2025.
- Keywords included 'patient navigation' and 'navigator in postdiagnosis cancer care-contact metrics'.
- Analyzed median contacts, time per patient, common barriers, and improved outcomes, comparing with NAVAH trial data.
Main Results:
- Seven peer-reviewed studies met inclusion criteria.
- Patient-navigator contacts ranged from 1 to 119 (average 13.4), with NAVAH averaging 2 contacts/month.
- Median time per patient varied widely (40 minutes to >10 hours), compared to NAVAH's 20 minutes/encounter. Financial assistance was a common barrier, consistent with NAVAH.
Conclusions:
- Published data on cancer patient navigation metrics shows significant variability.
- There is a clear need for standardized data collection and reporting practices.
- Standardized quantitative data is vital for the advancement of patient navigation in cancer care.
Related Concept Videos
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

